Memantine and condition aggravated 
Memantine and condition aggravated Patient Reports February 12, 2012
Memantine Side Effects Report #4778827-6
Memantine side effect was reported by a Health Professional from GERMANY on June 28, 2005. Male patient, 77 years of age, was diagnosed with open angle glaucoma and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, bipolar disorder
, cognitive deterioration, condition aggravated, depression , intentional self-injury, pressure of speech, sleep apnoea syndrome, upper respiratory tract infection. Memantine dosage: 20 MG QD PO. During the same period patient was treated with PARACETAMOL, ATORVASTATIN, NITROGLYCERIN, CALCIUM CARBONATE, ASPIRIN, METOPROLOL SUCCINATE, ISOSORBIDE, PROTONIX. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #4795030-4
Memantine side effect was reported by a Physician from UNITED STATES on Sept 28, 2005. Female patient, 54 years of age, weighting 186.0 lb, was diagnosed with mania, bipolar disorder
and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, bipolar disorder , condition aggravated, contusion, depression , fall , mania, pressure of speech. Memantine dosage: 30 MG QD PO. During the same period patient was treated with RISPERIDONE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, HUMULIN REGULAR, PROTONIX, METFORMIN, LISINOPRIL, REGLAN. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5130733-3
Memantine side effect was reported by a Physician from UNITED STATES on Oct 18, 2006. Male patient, weighting 140.0 lb, was diagnosed with dyskinesia, dystonia
and was treated with Memantine. After drug was administered, patient experienced the following side effects: condition aggravated, post concussion syndrome, rash erythematous, rash papular, rash pustular, stevens-johnson syndrome. Memantine dosage: unknown. During the same period patient was treated with AMANTADINE. Patient recovered.Memantine Side Effects Report #4922745-7
Memantine side effect was reported by a Health Professional from GERMANY on Feb 10, 2006. Female patient, 99 years of age, weighting 72.75 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: condition aggravated. Memantine dosage: unknown. During the same period patient was treated with CHOLINESTERASE INHIBITOR. Patient died on 07/10/2005.
Memantine Side Effects Report #5391702-1
Memantine side effect was reported by a Health Professional from GERMANY on July 02, 2007. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: c-reactive protein increased, chest pain
, cholecystitis, cholelithiasis, condition aggravated, heart rate increased, pyrexia. Memantine dosage: unknown. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOYXCHOLIC ACID, MIDODRINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5722911-7
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Apr 11, 2008. Female patient, 87 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, bundle branch block left, cognitive disorder, condition aggravated, disorientation, ecchymosis, fall
, haemoglobin decreased, micturition disorder. Memantine dosage: unknown. During the same period patient was treated with OMEPRAZOLE, COZAAR, SERTRALINE. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5626071-2
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Jan 28, 2008. Female patient, 85 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: condition aggravated, immobile, venous thrombosis, weight increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, FLECAINIDE ACETATE, VOLTAREN. Patient recovered.
Memantine Side Effects Report #5203507-2
Memantine side effect was reported by a Health Professional from FRANCE on Dec 20, 2006. Male patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, apathy, condition aggravated, dyspraxia, gait disturbance, mood swings, speech disorder. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, CITALOPRAM HYDROBROMIDE, KARDEGIC, SECTRAL, PRAVASTATIN, RABEPRAZOLE. Patient recovered.
Memantine Side Effects Report #4745129-3
Memantine side effect was reported by a Health Professional from GERMANY on July 30, 2005. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain
, condition aggravated. Memantine dosage: 5 MG QD PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, TAMOXIFEN CITRATE, VALERIANA OFFICINALIS ROOT. Patient was hospitalized. Patient died on 07/22/2005.Memantine Side Effects Report #4916469-X
Memantine side effect was reported by a Health Professional from GERMANY on Feb 10, 2006. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain
, condition aggravated. Memantine dosage: 5 MG QD PO. During the same period patient was treated with GALANTAMINE, TAMOXIFEN CITRATE, VALERIANA OFFICINALIS ROOT. Patient was hospitalized. Patient died on 07/22/2005.Memantine Side Effects Report #5071849-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on July 21, 2006. Male patient, 83 years of age, weighting 116.8 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: condition aggravated, lumbar spinal stenosis. Memantine dosage: unknown. During the same period patient was treated with INSULIN, MECOBALAMIN, LIMAPROST ALFADEX. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5650243-4
Memantine side effect was reported by a Consumer or non-health professional from ITALY on Feb 14, 2008. Male patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: bone marrow toxicity, condition aggravated, erythropenia, influenza, leukopenia, myocardial infarction, pulmonary embolism
, thrombocytopenia. Memantine dosage: 20 MG QD;PO. During the same period patient was treated with METFORMIN, RAMIPRIL, TRAZODONE. Patient recovered.Memantine Side Effects Report #5215337-6
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Dec 28, 2006. Female patient, 82 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: condition aggravated, dementia alzheimer's type, dry mouth, epilepsy
, partial seizures. Memantine dosage: 20 MG QD PO. During the same period patient was treated with LAMICTAL. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5599300-1
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Jan 03, 2008. Male patient, 82 years of age, weighting 174.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain
, condition aggravated, depression , dizziness , gait disturbance, malaise, transaminases increased. Memantine dosage: 10 MG QD PO. During the same period patient was treated with PAROXETINE, EQUANIL, ZOPICLONE, TAMSULOSIN. Patient recovered.Memantine Side Effects Report #4551122-6
Memantine side effect was reported by a Physician from on Dec 27, 2004. Female patient, 82 years of age, weighting 127.0 lb, was diagnosed with dementia alzheimer's type, hypertension and was treated with Memantine. After drug was administered, patient experienced the following side effects: cardiac murmur, cerebral ischaemia, computerised tomogram thorax abnormal, condition aggravated, dilatation atrial, dizziness
, electrocardiogram qt prolonged, fall , head injury. Memantine dosage: 20 MG QD PO. During the same period patient was treated with BISOPROLOL FUMARATE, SERTRALINE, GINKGO BILOBA, VITAMIN E, ENTERIC COATED ASPIRIN. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5239177-7
Memantine side effect was reported by a Health Professional from JAPAN on Jan 31, 2007. Female patient, 80 years of age, weighting 85.98 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: bedridden, condition aggravated, dementia alzheimer's type. Memantine dosage: 15 MG QD PO. During the same period patient was treated with SCOPOLAMINE BUTYLBROMIDE, FAMOTIDINE, REBAMIPIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5102577-X
Memantine side effect was reported by a Health Professional from JAPAN on Aug 24, 2006. Male patient, 80 years of age, weighting 121.5 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: amnesia, condition aggravated, gait disturbance, lung disorder, pleurisy, pneumonia
, tachycardia, wheezing. Memantine dosage: 20 MG QD PO. During the same period patient was treated with TOCOPHEROL NICOTINATE, UBIDECARENONE, NAFTOPIDIL, SENNOSIDE. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5107768-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Sept 07, 2006. Male patient, 80 years of age, weighting 121.5 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: amnesia, body height increased, condition aggravated, gait disturbance, hypoxia, lung disorder, pleural calcification, pyothorax, tachycardia. Memantine dosage: 20 MG QD PO. During the same period patient was treated with TOCOPHEROL NICOTINATE, UBIDECARRENONE, NAFTOPIDIL, SENNOSIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5550345-7
Memantine side effect was reported by a Health Professional from GERMANY on Nov 28, 2007. Female patient, 80 years of age, weighting 85.98 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: bedridden, condition aggravated, dementia alzheimer's type. Memantine dosage: 15 MG QD PO. During the same period patient was treated with PRAVASTATIN, CALCITRIOL, POTASSIUM ASPARTATE, TOCOPHEROL CONCENTRATE CAP, OFLOXACIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4918223-1
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Feb 10, 2006. Female patient, 80 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: c-reactive protein increased, condition aggravated, creatinine renal clearance decreased, grand mal convulsion, hemiplegia, pyrexia. Memantine dosage: 5 MG QD PO. During the same period patient was treated with SPASFON, CITALOPRAM HYDROBROMIDE, ARICEPT, DURAGESIC, PLAVIX, EQUANIL, ISOPTIN, PRAVASTATIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5023108-9
Memantine side effect was reported by a Health Professional from FRANCE on May 18, 2006. Male patient, 79 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, condition aggravated, disorientation, fall
, gait disturbance, hydrocephalus , ill-defined disorder, incontinence, memory impairment. Memantine dosage: 10 MG BID PO. During the same period patient was treated with EFFEXOR, REMINYL. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5404679-7
Memantine side effect was reported by a Health Professional from GERMANY on Nov 14, 2005. Male patient, 78 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anaemia, blood disorder, chronic lymphocytic leukaemia, condition aggravated, fluid retention, hepatocellular damage, splenomegaly. Memantine dosage: 10 MG BID PO. During the same period patient was treated with QUETIAPINE FUMARATE, TRAZODONE, LOXAPINE, ASPIRIN, RABEPRAZOLE, TEGRETOL, ACETAMINOPHEN. Patient recovered.
Memantine Side Effects Report #5675833-4
Memantine side effect was reported by a Pharmacist from UNITED STATES on Mar 03, 2008. Female patient, 78 years of age, was diagnosed with dementia alzheimer's type, prophylaxis urinary tract infection and was treated with Memantine. After drug was administered, patient experienced the following side effects: abasia, aggression, balance disorder, cerebral atrophy, cerebral ischaemia, condition aggravated, constipation
, delirium, delusion. Memantine dosage: MG. During the same period patient was treated with CARBIDOPA AND LEVODOPA, TRIMETHOPRIM, DONEPEZIL, FAMOTIDINE, PAROXETINE, LISINOPRIL AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5650230-6
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Feb 17, 2008. Male patient, 77 years of age, weighting 121.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: carotid artery stenosis, cerebral artery stenosis, condition aggravated, glaucoma
, intraocular pressure increased, retinal vein occlusion, visual acuity reduced. Memantine dosage: 20 MG QD; PO. During the same period patient was treated with AMLODIPINE BESYLATE, BRINZOLAMIDE, BUNAZOSIN HYDROCHLORIDE, LATANOPROST, TIMOLOL MALEATE. Patient was hospitalized and became disabled. Patient recovered.Memantine Side Effects Report #6025518-X
Memantine side effect was reported by a Health Professional from GERMANY on Dec 17, 2008. Male patient, 76 years of age, weighting 121.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, anger, condition aggravated, delirium, dementia alzheimer's type, hypophagia, insomnia, nuclear magnetic resonance imaging brain abnormal, physical abuse. Memantine dosage: 20 MG (20 MG,1 IN 1 D),ORAL. During the same period patient was treated with TIAPRIDE HYDROCHLORIDE, MIANSERIN HYDROCHLORIDE, MAGNESIUM OXIDE, SENNOSIDE, AZULENE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5421468-8
Memantine side effect was reported by a Physician from UNITED STATES on Aug 07, 2007. Female patient, 75 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: acute prerenal failure, agitation, blood pressure decreased, body temperature increased, cardiomegaly, condition aggravated, dehydration, fall
. Memantine dosage: 28 MG QD PO. During the same period patient was treated with LIPITOR, ALLEGRA, EXELON, PRILOSEC, CALCIUM, CENTRUM SILVER, ASPIRIN, GLYCOLAX. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #4874800-8
Memantine side effect was reported by a Pharmacist from SPAIN on Dec 21, 2005. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, condition aggravated, dementia
, hallucination, visual, mental status changes, parkinsonism. Memantine dosage: unknown. Patient recovered.Memantine Side Effects Report #5328629-7
Memantine side effect was reported by a Consumer or non-health professional from ITALY on Apr 27, 2007. Female patient, 73 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, cerebral atrophy, condition aggravated, gait disturbance, hallucination, visual. Memantine dosage: 5 MG QD PO. During the same period patient was treated with PAROXETINE, GALANTAMINE HYDROBROMIDE, QUETIAPINE FUMARATE, VITAMIN E. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5989145-2
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Nov 28, 2008. Female patient, 72 years of age, weighting 134.5 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: condition aggravated, constipation
, dementia alzheimer's type, restlessness. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5258236-6
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Feb 28, 2007. Male patient, 69 years of age, weighting 146.4 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: aggression, agitation, condition aggravated, dementia alzheimer's type, expressive language disorder, libido increased, paranoia, psychiatric symptom, restlessness. Memantine dosage: unknown. During the same period patient was treated with FERROUS CITRATE, REBAMIPIDE, AMLODIPINE BESYLATE, CILNIDIPINE, BIPERIDEN HYDROCHLORIDE, HALOPERIDOL, VALPROIC ACID, ZONISAMIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5315164-5
Memantine side effect was reported by a Health Professional from JAPAN on Apr 19, 2007. Male patient, 69 years of age, weighting 146.4 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, aggression, agitation, condition aggravated, libido increased, paranoia, persecutory delusion, poriomania, restlessness. Memantine dosage: unknown. During the same period patient was treated with FERROUS CITRATE, REBAMIPIDE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5346616-X
Memantine side effect was reported by a Health Professional from JAPAN on May 24, 2007. Male patient, 69 years of age, weighting 146.4 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: aggression, condition aggravated, libido increased, paranoia, persecutory delusion, psychiatric symptom. Memantine dosage: unknown. During the same period patient was treated with FERROUS CITRATE, REBAMIPIDE, AMLODIPINE BESYLATE, CLINIDIPINE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4744969-4
Memantine side effect was reported by a Physician from UNITED STATES on Aug 04, 2005. Male patient, 67 years of age, weighting 158.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin abnormal, colitis, condition aggravated, gastritis, haemoglobin decreased, hypokalaemia, hyponatraemia, hypotension, malnutrition. Memantine dosage: 20 MG QD PO. During the same period patient was treated with METRONIDAZOLE, TRAZODONE, LIPITOR, FLOMAX. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #6138572-1
Memantine side effect was reported by a Pharmacist from GERMANY on Mar 11, 2009. Female patient, 63 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: aggression, condition aggravated, convulsion, eructation, extrapyramidal disorder, galactorrhoea, hypothyroidism, irritability, protrusion tongue. Memantine dosage: unknown. During the same period patient was treated with DONEPEZIL, QUETIAPINE FUMARATE, TOPIRAMATE, HALOPERIDOL, PROMAZINE HYDROCHLORIDE. Patient recovered.
Memantine Side Effects Report #5385507-5
Memantine side effect was reported by a Health Professional from FRANCE on June 26, 2007. Male patient, 61 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: bronchospasm, condition aggravated. Memantine dosage: 10 MG BID PO. During the same period patient was treated with EXELON, FORADIL, MIFLASONE, STABLON, ASPIRIN, PRAVASTATIN. Patient recovered.
Memantine Side Effects Report #5201425-7
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2006. Female patient, weighting 85.98 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: asthenia, bedridden, condition aggravated, dementia alzheimer's type. Memantine dosage: unknown. During the same period patient was treated with SCOPOLAMINE BUTYLBROMIDE, FAMOTIDINE, REBAMIPIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5009837-1
Memantine side effect was reported by a Health Professional from FRANCE on May 05, 2006. Female patient, 80 years of age, was diagnosed with dementia
and was treated with Memantine. After drug was administered, patient experienced the following side effects: condition aggravated, petit mal epilepsy. Memantine dosage: unknown. During the same period patient was treated with EXELON, PLAVIX, DITROPAN, AMLODIPINE BESYLATE, URBANYL. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5023107-7
Memantine side effect was reported by a Health Professional from FRANCE on May 22, 2006. Female patient, 79 years of age, weighting 132.3 lb, was diagnosed with dementia
and was treated with Memantine. After drug was administered, patient experienced the following side effects: condition aggravated, petit mal epilepsy. Memantine dosage: unknown. During the same period patient was treated with EXELON, ATHYMIL, PLAVIX, DITROPAN, AMLODIPINE BESYLATE, URBANYL. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5811776-0
Memantine side effect was reported by a Consumer or non-health professional from SWITZERLAND on June 26, 2008. Male patient, 66 years of age, was diagnosed with dementia
and was treated with Memantine. After drug was administered, patient experienced the following side effects: bipolar disorder , condition aggravated, hypomania. Memantine dosage: 15 MG QD PO. During the same period patient was treated with CYMBALTA, PRAZINE, XANAX, RISPERDAL, REMERON. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5810796-X
Memantine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 12, 2008. Female patient, 48 years of age, was diagnosed with dementia
and was treated with Memantine. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, dementia , grand mal convulsion, posture abnormal. Memantine dosage: 5 MG BID PO. During the same period patient was treated with LEVOTHYROXINE, VALPROATE. Patient recovered.Memantine Side Effects Report #5768868-4
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on May 26, 2008. Female patient, 81 years of age, weighting 99.21 lb, was diagnosed with cognitive disorder and was treated with Memantine. After drug was administered, patient experienced the following side effects: anxiety
, balance disorder, condition aggravated, disorientation, major depression. Memantine dosage: 20 MG QD PO. During the same period patient was treated with IRBESARTAN, STABLON, LEVOTHYROXINE, KEPPRA. Patient recovered.Memantine Side Effects Report #4891911-1
Memantine side effect was reported by a Health Professional from SPAIN on Jan 09, 2006. Male patient, 74 years of age, was diagnosed with cognitive disorder, dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, condition aggravated, dementia
, hallucination, visual, parkinsonism. Memantine dosage: 5 MG. During the same period patient was treated with RISPERIDONE, DONEPEZIL, RIVASTIGMINE, ENALAPRIL. Patient recovered.Memantine Side Effects Report #5489224-2
Memantine side effect was reported by a Physician from UNITED STATES on Oct 03, 2007. Male patient, 66 years of age, weighting 171.3 lb, was diagnosed with cognitive disorder, dementia
, parkinson's disease and was treated with Memantine. After drug was administered, patient experienced the following side effects: anxiety , condition aggravated, dyspraxia, hallucination, visual, initial insomnia, middle insomnia, paranoia, parkinson's disease , prostatitis. Memantine dosage: unknown. Patient recovered.Memantine Side Effects Report #4913550-6
Memantine side effect was reported by a Health Professional from SPAIN on Jan 26, 2006. Male patient, 74 years of age, was diagnosed with cognitive deterioration, dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, cerebral atrophy, condition aggravated, dementia
, depressed level of consciousness, hallucination, visual, parkinsonism. Memantine dosage: 5 MG QD. During the same period patient was treated with RISPERIDONE, DONEPEZIL, RIVASTIGMINE, ENALAPRIL MALEATE. Patient recovered.Memantine Side Effects Report #4792208-0
Memantine side effect was reported by a Physician from UNITED STATES on Sept 29, 2005. Female patient, 54 years of age, weighting 186.0 lb, was diagnosed with bipolar disorder
, mania and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, bipolar disorder , condition aggravated, contusion, depression , fall , mania, pressure of speech. Memantine dosage: 30 MG QD PO. During the same period patient was treated with RISPERIDONE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, HUMULIN REGULAR, PROTONIX, METFORMIN, LISINOPRIL. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5776252-2
Memantine side effect was reported by a Health Professional from FRANCE on May 29, 2008. Female patient, 85 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: bronchospasm, bundle branch block right, condition aggravated, hypothyroidism, left ventricular hypertrophy, oedema peripheral, rales, renal failure chronic, sinus bradycardia. Memantine dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, PRAVASTATIN, FUROSEMIDE, LEVOTHYROXINE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5678258-0
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Mar 10, 2008. Female patient, 81 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: balance disorder, condition aggravated, major depression. Memantine dosage: 20 MG QD PO. During the same period patient was treated with IRBESARTAN, STABLON, LEVOTHYROXINE, KEPPRA. Patient recovered.